PDGFRB and ovarian serous adenocarcinoma: In contrast, the analyses of serous ovarian cancer and renal cell cancer patients identified a statistically significant relationship between high pericyte coverage (determined by PDGFR-β and α-SMA respectively) and poor prognosis [17, 26].